Related Topics
We're better off with mRNA vaccines
The technology that is helping us combat COVID-19 is also poised to help us tackle tough infectious and non-infectious diseases. Immunologist Sarah Fortune explains how these vaccines work, and how the mRNA platform could transform the prevention and…
Ensuring safe and effective COVID-19 vaccines for vulnerable populations
Although COVID-19 vaccines have begun reaching people around the world, challenges remain to ensuring that the vaccines help those who are most vulnerable, according to an article co-authored by experts from Harvard T.H. Chan School of Public Health.
‘An enormous victory for public health’
Jaap Goudsmit, adjunct professor of epidemiology and infectious diseases and chief scientific officer of the Human Immunomics Initiative, a joint project between Harvard Chan School and the Human Vaccines Project, discusses COVID vaccines.
Marc Lipsitch, Pardis Sabeti elected to National Academy of Medicine
Two Harvard T.H. Chan School of Public Health faculty members, Marc Lipsitch and Pardis Sabeti, have been elected to the National Academy of Medicine.
Frontlines Fall 2020
Quick updates about the latest public health news from across the School and beyond.
Bearing witness
Harvard Chan School scientists at the forefront of the pandemic response share their stories of stress, exhaustion, anger, grief, gratitude, and soul-searching.
The Connected Crisis
The COVID-19 pandemic has inspired new research directions across the School
Innovations through Public Health History
A sample of “next-generation” ideas from the past
A coronavirus Q&A with immunologist Sarah Fortune
Numerous topics about COVID-19—such as how COVID-19 deaths compare to influenza deaths, or how likely it is to get COVID-19 from airborne transmission—were discussed in a May 1, 2020 C-SPAN interview featuring Sarah Fortune, John LaPorte Given Professor…
Perspective: COVID-19 highlights pressing need to better understand immunity, particularly in elderly
The COVID-19 pandemic has highlighted the vulnerability of aging populations to emerging diseases and underscores the significant need to better understand immunity and vaccine response among the elderly, according to an April 17, 2020 New England Journal of…